|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/0051 | (2013.01) |
| A61L 27/38 | (2006.01) | ||
| A61K 35/12 | (2015.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| C12N 5/0012 | (2013.01) | ||
| C12N2510/02 | (2013.01) | ||
| A61F 9/00 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/02 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61P 27/12 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 3043836 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14776945.9 |
| Europos patento paraiškos padavimo data | 2014-09-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/055028 |
| Data | 2014-09-10 |
| (87) | Numeris | WO 2015/038669 |
| Data | 2015-03-19 |
| (30) | Numeris | Data | Šalis |
| 201361876638 P | 2013-09-11 | US |
| (72) |
KAUPER, Konrad A. , US
MILLS, John Fraser , US
BILLINGS, Megan , US
RIVERA, Michael R. , US
LELIS, Alline Monteiro Alcantara , US
|
| (73) |
Neurotech USA, Inc. ,
900 Highland Corporate Drive
Building No. 1
Suite No. 101, Cumberland, RI 02864,
US
|
| (54) | ENCAPSULATED CELL THERAPY CARTRIDGE |
| ENCAPSULATED CELL THERAPY CARTRIDGE |